Margaret E O'Neil1, Maria A Fragala-Pinkham2, Jeffrey L Forman3, Stewart G Trost4. 1. Department of Physical Therapy and Rehabilitation Sciences, College of Nursing and Health Professions, Drexel University, Philadelphia, PA, USA. 2. Franciscan Hospital for Children, Research Center for Children with Special Health Care Needs, Brighton, MA, USA. 3. Department of Pediatric Rehabilitation Medicine, Franciscan Hospital for Children, Brighton, MA, USA. 4. Queensland Institute of Technology, Institute of Health and Biomedical Innovation, St Lucia, QLD, Australia.
Abstract
PURPOSE: The purposes of this study were to: 1) establish inter-instrument reliability between left and right hip accelerometer placement; 2) examine procedural reliability of a walking protocol used to measure physical activity (PA); and 3) confirm concurrent validity of accelerometers in measuring PA intensity as compared to the gold standard of oxygen consumption measured by indirect calorimetry. METHODS: Eight children (mean age: 11.9; SD: 3.2, 75% male) with CP (GMFCS levels I-III) wore ActiGraph GT3X accelerometers on each hip and the Cosmed K4b<formula>^{2}</formula> portable indirect calorimeter during two measurement sessions in which they performed the six minute walk test (6MWT) at three self-selected speeds (comfortable/slow, brisk, fast). Oxygen consumption (VO2) and accelerometer step and activity count data were recorded. RESULTS: Inter-instrument reliability of ActiGraph GT3X accelerometers placed on left and right hips was excellent (ICC=0.96-0.99, CI<formula>_{95}</formula>: 0.81-0.99). Reproducibility of the protocol was good/excellent (ICC=0.75-0.95, CI<formula>_{95}</formula>: 0.75-0.98). Concurrent validity of accelerometer count data and VO2 was fair/good (rho=0.67, p< 0.001). The correlation between step count and VO2 was not significant (rho=0.29, p=0.2). CONCLUSION: This preliminary research suggests that ActiGraph GT3X accelerometers are reliable and valid devices to monitor PA during walking in children with CP and may be appropriate in rehabilitation research and clinical practice. ActiGraph GTX3 step counts were not valid for this sample and further research is warranted.
PURPOSE: The purposes of this study were to: 1) establish inter-instrument reliability between left and right hip accelerometer placement; 2) examine procedural reliability of a walking protocol used to measure physical activity (PA); and 3) confirm concurrent validity of accelerometers in measuring PA intensity as compared to the gold standard of oxygen consumption measured by indirect calorimetry. METHODS: Eight children (mean age: 11.9; SD: 3.2, 75% male) with CP (GMFCS levels I-III) wore ActiGraph GT3X accelerometers on each hip and the Cosmed K4b<formula>^{2}</formula> portable indirect calorimeter during two measurement sessions in which they performed the six minute walk test (6MWT) at three self-selected speeds (comfortable/slow, brisk, fast). Oxygen consumption (VO2) and accelerometer step and activity count data were recorded. RESULTS: Inter-instrument reliability of ActiGraph GT3X accelerometers placed on left and right hips was excellent (ICC=0.96-0.99, CI<formula>_{95}</formula>: 0.81-0.99). Reproducibility of the protocol was good/excellent (ICC=0.75-0.95, CI<formula>_{95}</formula>: 0.75-0.98). Concurrent validity of accelerometer count data and VO2 was fair/good (rho=0.67, p< 0.001). The correlation between step count and VO2 was not significant (rho=0.29, p=0.2). CONCLUSION: This preliminary research suggests that ActiGraph GT3X accelerometers are reliable and valid devices to monitor PA during walking in children with CP and may be appropriate in rehabilitation research and clinical practice. ActiGraph GTX3 step counts were not valid for this sample and further research is warranted.
Authors: Bonny Rockette-Wagner; Kristi L Storti; Sharon Edelstein; Linda M Delahanty; Bryan Galvin; Alexandra Jackson; Andrea M Kriska Journal: Child Obes Date: 2016-02-09 Impact factor: 2.992
Authors: Donovan J Lott; Tanja Taivassalo; Claudia R Senesac; Rebecca J Willcocks; Ann M Harrington; Kirsten Zilke; Hilary Cunkle; Catherine Powers; Erika L Finanger; William D Rooney; Gihan I Tennekoon; Krista Vandenborne Journal: Muscle Nerve Date: 2020-11-27 Impact factor: 3.217
Authors: Kerri N Boutelle; Abby Braden; Jennifer M Douglas; Kyung E Rhee; David Strong; Cheryl L Rock; Denise E Wilfley; Leonard Epstein; Scott Crow Journal: Contemp Clin Trials Date: 2015-09-08 Impact factor: 2.226
Authors: Kavya S Nair; Donovan J Lott; Sean C Forbes; Alison M Barnard; Rebecca J Willcocks; Claudia R Senesac; Michael J Daniels; Ann T Harrington; Gihan I Tennekoon; Kirsten Zilke; Erika L Finanger; Richard S Finkel; William D Rooney; Glenn A Walter; Krista Vandenborne Journal: J Neuromuscul Dis Date: 2022
Authors: Vaka Rognvaldsdottir; Berglind M Valdimarsdottir; Robert J Brychta; Soffia M Hrafnkelsdottir; Sigurbjorn A Arngrimsson; Erlingur Johannsson; Kong Y Chen; Sigridur L Gudmundsdottir Journal: Laeknabladid Date: 2018-02 Impact factor: 0.548
Authors: Matthew Ahmadi; Margaret O'Neil; Maria Fragala-Pinkham; Nancy Lennon; Stewart Trost Journal: J Neuroeng Rehabil Date: 2018-11-15 Impact factor: 4.262